Reported Mar 19, 2014 · Terminated
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only,…
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · 1718 Northrock Ct · Rockford, IL · 61103-1201
Is this the product you have?
- Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only
- Manufactured forQualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20
- Lot codes and dates
- Lots and Expiration Dates
3037463Expires 2/20143039466Expires 3/20143040644Expires 4/20143043463Expires 6/20143049568Expires 3/2015
- Lots and Expiration Dates
- Amount recalled
- 3,252 cartons
Where it was sold
- Nationwide
Why it was recalled
Failed Impurity/degradation Specification
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Institutional, Inc. (d.b.a. UDL… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.